Abstract
Surface plasmon resonance measurements were used for detecting and quantifying protein-protein interactions between the tumorsuppressor protein p53, the SV40 large T antigen (T-ag), the cellular DNA polymerase α-primase complex (pol-prim), and the cellular single-strand DNA binding protein RPA. Highly purified p53 protein bound to immobilized T-ag with an apparent binding constant of 2×108 M−1. Binding of p53 to RPA was in the same order of magnitude with a binding constant of 4×108 M−1, when RPA was coupled to the sensor chip via its smallest subunit, and 1×108 M−1, when RPA was coupled via its p70 subunit. Furthermore, p53 bound human DNA polymerase α-primase complex (pol-prim) with a KA value of 1×1010 M−1. Both the p68 subunit and the p180 subunit of pol-prim could interact with p53 displaying binding constants of 2×1010 M−1 and 5×109 M−1, respectively. Complex formation was also observed with a p180/p68 heterodimer, and again with a binding constant similar. Hence, there was no synergistic effect when p53 bound to higher order complexes of pol-prim. A truncated form of p53, consisting of amino acids 1 – 320, bound pol-prim by four orders of magnitude less efficiently. Therefore, an intact C-terminus of p53 seems to be important for efficient binding to pol-prim. It was also tried to measure complex formation between p53, pol-prim, and T-ag. However there was no evidence for the existence of a ternary complex consisting of T-ag, pol-prim, and p53.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agarwal ML, Taylor WR, Chernov MV, Chernova OB and Stark GR. . 1998 J. Biol. Chem. 273: 1–4.
Anderson ME, Woelker B, Reed M, Wang P and Tegtmeyer P. . 1997 Mol. Cell. Biol. 17: 6255–6264.
Boulikas T. . 1996 Anticancer Res. 16: 693–708.
Bradford MM. . 1976 Anal. Biochem. 72: 248–254.
Braithwaite AW, Stürzbecher H-W, Addison C, Palmer C, Rudge K and Jenkins JR. . 1987 Nature 329: 458–460.
Collins KL, Russo AAR, Tseng BY and Kelly TJ. . 1993 EMBO J. 12: 4555–4566.
Cox LS and Lane DP. . 1995 Bioessays 17: 501–508.
Dornreiter I, Erdile LF, Gilbert IU, von Winkler D, Kelly TJ and Fanning E. . 1992 EMBO J. 11: 769–776.
Dornreiter I, Höss A, Arthur AK and Fanning E. . 1990 EMBO J. 9: 3329–3336.
Dutta A, Ruppert JM, Aster JC and Winchester E. . 1993 Nature 365: 79–82.
Ford JM and Hanawalt PC. . 1997 J. Biol. Chem. 272: 28073–28080.
Fortunato EA and Spector DH. . 1998 J. Virol. 72: 2033–2039.
Gannon JV and Lane D. . 1987 Nature 329: 456–458.
Gannon JV and Lane DP. . 1990 New Biol. 2: 84–92.
He Z, Brinton BT, Greenblatt J, Hassell JA and Ingles CJ. . 1993 Cell 73: 1223–1232.
Henricksen LA, Umbricht CB and Wold MS. . 1994 J. Biol. Chem. 269: 11121–11132.
Hochuli E, Gillessen D and Kocher HP. . 1987 J. Chromat. 411: 371–378.
Jayaraman L and Prives C. . 1995 Cell 81: 1021–1029.
Kernohan NM, Hupp TR and Lane DP. . 1996 J. Biol. Chem. 271: 4954–4960.
Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.
Lane DP and Crawford LV. . 1979 Nature 278: 261–263.
Lee S, Elenbaas B, Levine A and Griffith J. . 1995 Cell 81: 1013–1020.
Levine AJ. . 1997 Cell 88: 323–331.
Li R and Botchan MR. . 1993 Cell 73: 1207–1221.
Li R, Yu DS, Tanaka M, Zheng L, Berger SL and Stillman B. . 1998 Mol. Cell. Biol. 18: 1296–1302.
Linzer DI and Levine AJ. . 1979 Cell 17: 43–52.
Melendy T and Stillman B. . 1993 J. Biol. Chem. 268: 3389–3395.
Moarefi IF, Small D, Gilbert I, Höpfner M, Randall SK, Schneider C, Russo AAR, Ramsperger U, Arthur AK, Stahl H, Kelly TJ and Fanning E. . 1993 J. Virol. 67: 4992–5002.
Mummenbrauer T, Janus F, Müller B, Wiesmüller L, Deppert W and Grosse F. . 1996 Cell 85: 1089–1099.
Schmieg FI and Simmons DT. . 1988 Virology 164: 132–140.
Stadlbauer F, Brueckner A, Rehfuess C, Eckerskorn C, Lottspeich F, Förster V, Tseng BY and Nasheuer H-P. . 1994 Eur. J. Biochem. 222: 781–793.
Stadlbauer F, Voitenleitner C, Brückner A, Fanning E and Nasheuer HP. . 1996 Mol. Cell. Biol. 16: 94–104.
Tanaka S, Hu S-Z, Wang TS-F and Korn D. . 1982 J. Biol. Chem. 256: 8386–8390.
Wang XW and Harris CC. . 1997 J. Cell. Physiol. 173: 247–255.
Wang Y, Reed M, Wang P, Stenger JE, Mayr G, Anderson ME, Schwedes JF and Tegtmeyer P. . 1993 Genes Dev. 7: 2575–2586.
Warbrick E. . 1996 Curr. Biol. 6: 1057–1059.
Wilcock D and Lane DP. . 1991 Nature 349: 429–431.
Acknowledgements
We are grateful to Dr K Weisshart for his generous gift of SV40 T-ag and human RPA, and to Dr I Dornreiter for communication of data prior to publication, and Dr R Smith for critical reading of the manuscript. This work was supported by grants from the Deutsche Krebschilfe. Fonds der Chemischen Industrie, and Deutsche Forschungsgemeinschaft.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kühn, C., Müller, F., Melle, C. et al. Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase α. Oncogene 18, 769–774 (1999). https://doi.org/10.1038/sj.onc.1202327
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202327
Keywords
This article is cited by
-
DNA-PK, ATM and ATR collaboratively regulate p53–RPA interaction to facilitate homologous recombination DNA repair
Oncogene (2013)
-
Plasmonic DNA: Towards Genetic Diagnosis Chips
Plasmonics (2007)
-
Wild-type p53 inhibits replication-associated homologous recombination
Oncogene (2002)
-
p53 and recombination intermediates: role of tetramerization at DNA junctions in complex formation and exonucleolytic degradation
Oncogene (2002)
-
Association of p53 and MSH2 with recombinative repair complexes during S phase
Oncogene (2002)